Canopy River eyeing biosynthesis investment within next year

Several biotechnology firms are moving toward synthetic production of THC, CBD and other cannabinoids in a lab, using ingredients such as sugar and yeast, which if successful, can potentially produce these active compounds more cheaply than traditional cultivation and extraction.

Meanwhile, although there is growing buzz around magic mushrooms and the medicinal applications of psilocybin and Canopy Rivers has received some pitches from companies in this space, Alexandrian believes it is too early for an investment. He says that, compared to cannabis, the stigma is larger and the number of people who have tried magic mushrooms is fewer, but Canopy Rivers is watching in case potential for medicinal psilocybin develops further.

Россия Последние новости, Россия Последние новости

Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей

Canopy Growth buys majority stake in sports drink company BioSteelCannabis company Canopy Growth Corp. has bought a majority stake in BioSteel Sports Nutrition Inc., a maker of sports nutrition products. FBenmans17 YourMorning Well wont be buying any more Bio Steel.
Источник: CTVNews - 🏆 1. / 99 Прочитайте больше »

Canopy Growth buys majority stake in sports drink company BioSteelCannabis company Canopy Growth Corp. has bought a majority stake in BioSteel Sports Nutrition Inc., a maker of sports nutrition products. FBenmans17 YourMorning Well wont be buying any more Bio Steel.
Источник: CTVNews - 🏆 1. / 99 Прочитайте больше »